Macular Degeneration: all 1,490 studies
Page 10 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Patient's Feelings After Receiving a Diagnosis of Age-related Macular DegenerationCompletedNCT03035461
- Macular Thickness Measurements Using Retinal-thickness OCTCompletedNCT03030729
- Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMDCompletedNCT03024424Not applicable
- A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular DegenerationStatus unknownNCT03021785Phase 1
- Telescope Exchange StudyStatus unknownNCT03011554Not applicable
- Episcleral Brachytherapy for the Treatment of Wet AMDActive, not recruitingNCT02988895Not applicable
- Intraocular Cytokine in Recurrence of Polypoidal Choroidal VasculopathyStatus unknownNCT02976194Phase 4
- "Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" StudyStatus unknownNCT02960828Not applicable
- Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular DegenerationCompletedNCT02944227Phase 4
- A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)CompletedNCT02941991
- MP3 (Microperimeter 3) Reproducibility in Healthy Subjects and Macular PatientsStatus unknownNCT02941406
- Natural History of Geographic Atrophy Associated With Age-Related Macular DegenerationCompletedNCT02941263
- Stem Cell Therapy for Outer Retinal DegenerationsCompletedNCT02903576Phase 1/2
- Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD)WithdrawnNCT02895815Phase 2
- Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic RetinopathyTerminatedNCT02875704
- A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular DegenerationWithdrawnNCT02873351Phase 2
- A Comparison of the Checkup Vision Assessment System to Standard Vision Assessment ToolsStatus unknownNCT02871817
- Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells TransplantationStatus unknownNCT02868424Early Phase 1
- The Impact of Two Strategies in the Monitoring of Exudative ARMD on the Visual Acuity (by OCT B Scan or OCT Angiography)CompletedNCT02868086Not applicable
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular EdemaCompletedNCT02867735Phase 1
- Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading DoseStatus unknownNCT02864472Phase 4
- Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's PatientsTerminatedNCT02863640
- Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMDCompletedNCT02859766Phase 1
- Functional and Structural Outcomes in Neovascular Age-related Macular DegenerationCompletedNCT02843490Phase 4
- Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)CompletedNCT02829606Not applicable
- Ocular Imaging Study Using Advanced OCTTerminatedNCT02827071
- Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in GreeceCompletedNCT02821247
- Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMDStatus unknownNCT02810808Phase 4
- Ocular Discomfort Assessment After Intravitreal InjectionsCompletedNCT02806830Not applicable
- Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal VasculopathyStatus unknownNCT02806752Phase 4
- " En Face " OCT's Contribution in the Detection of Macular Retinal Toxicity Signs Linked to the Chronic Treatment of Synthetic AntimalarialsCompletedNCT02805686Not applicable
- Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular DegenerationStatus unknownNCT02802657Phase 4
- PIIR Study: Comparison of Genetic Tests for Age-Related Macular DegenerationTerminatedNCT02779686
- Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)CompletedNCT02762188Not applicable
- Subretinal Transplantation of Retinal Pigment Epitheliums in Treatment of Age-related Macular Degeneration DiseasesStatus unknownNCT02755428Phase 1/2
- Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration DiseasesStatus unknownNCT02749734Phase 1/2
- Five-year Incidence of Age-related Macular Degeneration in the Central Region of PortugalCompletedNCT02748824
- Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular DegenerationStatus unknownNCT02747368Not applicable
- Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMDStatus unknownNCT02727881Phase 3
- Study of Photobiomodulation to Treat Dry Age-Related Macular DegenerationCompletedNCT02725762Not applicable
- Studying the Performance of OCT C-scan in the Screening for Retinopathy Related to Synthetic AntimalarialsCompletedNCT02719002Not applicable
- Multimodal Imaging of Retinal VesselsCompletedNCT02717026
- Cytokeratin 8 Level in Age-related Macular DegenerationCompletedNCT02707575
- BioCurrent Electrical Stimulation for the Treatment of Dry ARMDWithdrawnNCT02699216Not applicable
- PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLiberceptStatus unknownNCT02681783Phase 4
- CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumabWithdrawnNCT02634970Phase 4
- Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-ComtéTerminatedNCT02626377Not applicable
- Resveratrol for Exudative Age-Related Macular DegenerationTerminatedNCT02625376Not applicable
- Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for AfliberceptCompletedNCT02615496
- Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular DegenerationStatus unknownNCT02613559Phase 1
- Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMDStatus unknownNCT02599064Phase 1/2
- An Open-Label Investigator Sponsored Trial to Investigate the Safety, Tolerability and Development of Subfoveal Fibrosis By Intravitreal Administration of Altering Regimens of Fovista and Anti-VEGF Therapy in Subjects With Neovascular Age-Related Macular DegenerationCompletedNCT02591914Phase 1
- Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMDStatus unknownNCT02590692Phase 1/2
- The Role of Inflammation in AMD and Related DisordersStatus unknownNCT02588378
- Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in CanadaCompletedNCT02585401
- Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' PerspectiveCompletedNCT02567604
- Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMDWithdrawnNCT02563782Phase 2
- Technology-based Eye Care Services (TECS) CompareCompletedNCT02558712Not applicable
- Intravitreal Injections of Ziv-aflibercept for Macular DiseasesCompletedNCT02556723Not applicable
- Assessment of Scan Quality of Sparse OCT Retina Scanner (MimoStudy01)CompletedNCT02555995Not applicable
- Grid Laser for Diffuse Diabetic MaculopathyCompletedNCT02555956
- Incidence and Risk Factor of Hydroxychloroquine and Chloroquine RetinopathyStatus unknownNCT02550964
- Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT RegimenCompletedNCT02550002
- Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMDCompletedNCT02543229Phase 1
- Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in JapanCompletedNCT02541084
- To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.CompletedNCT02540369
- Transpalpebral Micro-Current Electrical Stimulation for the Treatment of Dry Age-Related Macular DegenerationCompletedNCT02540148Not applicable
- Study of DS-7080a for the Treatment of Macular DegenerationCompletedNCT02530918Phase 1
- Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction MaculopathyCompletedNCT02528058
- Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction MaculopathyCompletedNCT02528045
- Non-invasive Optical Angiography in Age-related Macular DegenerationStatus unknownNCT02521142
- Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular DegenerationWithdrawnNCT02511613Phase 2
- Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionStatus unknownNCT02486484Phase 2
- Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMDTerminatedNCT02467634Phase 2
- Production of iPSC Derived RPE Cells for Transplantation in AMDCompletedNCT02464956
- Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMDCompletedNCT02463344
- Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMDWithdrawnNCT02457026Not applicable
- Photodynamic Therapy for PDA in NV AMDCompletedNCT02452840
- Phase 1 Study of CM082 in Patients With wAMDSuspendedNCT02452385Phase 1
- Evaluation the Pharmacokinetics, Safety, Tolerability of BCD-021 in Patients With Neovascular Age-related Macular DegenerationWithdrawnNCT02450981Phase 1
- Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy PatientsCompletedNCT02445612
- Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry DeviceCompletedNCT02445313
- VITAL - Individualising Therapy for Neovascular AMD With AfliberceptCompletedNCT02441816Phase 4
- The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)Status unknownNCT02438111
- Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular DegenerationCompletedNCT02422160
- Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®)CompletedNCT02420132
- The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular DystrophyCompletedNCT02410122
- A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular DegenerationCompletedNCT02401945Phase 2
- A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationTerminatedNCT02399072
- Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular DegenerationTerminatedNCT02398500Phase 1/2
- Microperimetry and Eye Progressing From Stage 3 to Stage 4 Age-related Macular Degeneration (AMD)CompletedNCT02395757Not applicable
- Effects of Sea Buckthorn Oil and Lutein on Eye HealthStatus unknownNCT02379169Not applicable
- Geographic Atrophy and Intravitreal Ranibizumab InjectionsStatus unknownNCT02372916
- Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMDCompletedNCT02367365
- Reticular Pseudodrusen Progression StudyStatus unknownNCT02345317
- Evaluation of the Distortion Correction Data Collection (DCDC) App SoftwareCompletedNCT02337647Not applicable
- Treatment -Resistant Neovascular Age-Related Macular DegenerationCompletedNCT02332941Phase 1
- Sparing of the Fovea in Geographic Atrophy ProgressionCompletedNCT02332343
- Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular DegenerationStatus unknownNCT02328209Not applicable
- Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.CompletedNCT02321839Phase 4